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Gastric  ulcer  is  a prevalent  gastrointestinal  disease,  and  the  drugs  currently  used  in  the  treatment  produce
several  adverse  effects.  In this  context,  the  search  for new  therapeutic  antiulcer  agents  is essential,  and
medicinal  plants  have  great  potential.  Here,  we  investigated  the gastroprotective  properties  of  Copaifera
langsdorfﬁi  Desf.,  Fabaceae,  hydroalcoholic  extract obtained  from  leaves  and  its  isolated  compounds.
The  phytochemistry  studies  and the  compounds  isolations  were  performed  using  chromatographic  and
spectroscopic  methodologies.  The  hydroalcoholic  extract  was  evaluated  using  ethanol/HCl,  non-steroidal
anti-inﬂammatory  drug,  stress-induced-ulcer  and  chronic  ulcer-model.  The  effects  on gastric  content
volume,  pH,  total  acidity  and  mucus  stomach  production  were  evaluated  in  the  pylorus  ligated-model.
The  C.  langsdorfﬁi  extract  obtained  from  leaves  (50, 250  or 500  mg/kg)  reduced  the injured  area  com-
pared  to control  group  in all experiments.  The  extract  showed  a signiﬁcant  decrease  in the  total  gastric
juice  acidity  and  an  increase  in mucus  production  (500  mg/kg)  when  compared  to  vehicle.  Among  iso-
lated  compounds  (30  mg/kg)  -humulene,  -caryophyllene  and  caryophyllene  oxide  showed  greater
gastroprotective  activity  in the  ethanol/HCl  induced  ulcer  model.  The  data  herein  obtained  shown  that
C.  langsdorfﬁi  leaves  extract  and  isolated  compounds  from  it, presented  gastroprotective  properties  in
different  animal  models  of  gastric  ulcer.  These  effects  may  be associated  with  the  ability  of the  extract  to
decrease  gastric  secretion  and  increase  the  mucus  production.
ileira©  2015  Sociedade  Bras
ntroduction
Gastric ulcer is a chronic/recurrent disease and currently is the
ost predominant gastrointestinal disease. Studies have shown
hat gastric ulcer occurs in at least 10% of the world’s population
Freire et al., 2011; Shimoyama et al., 2013). The etiology of dis-
ase is not completely understood, however it is known that the
xtent of injuries to the gastric mucosa depends on the balance
etween aggressive and protective factors (Banic´et al., 2011). The
ajor protective factors include adequate blood ﬂow, secretion of
rostaglandins, mucus, and bicarbonate by resident mucosal cells.
ggressive agents include the increased secretion of hydrochlo-
ic acid and pepsin, inadequate dietary habits, the consumption of
onsteroidal anti-inﬂammatory drugs and alcohol, stressful condi-
ions, and infection by Helicobacter pylori (Klein-Júnior et al., 2012).
∗ Corresponding author.
E-mail: jrs.santin@univali.br (J.R. Santin).
http://dx.doi.org/10.1016/j.bjp.2015.05.005
102-695X/© 2015 Sociedade Brasileira de Farmacognosia. Published by Elsevier Editora de  Farmacognosia.  Published  by  Elsevier  Editora  Ltda.  All  rights  reserved.
Due to the high incidence of gastric ulcers, distinct pharmacolog-
ical therapies have been investigated. The main current therapies
are histamine receptor antagonists (H2-Ras) and/or proton pump
inhibitors (PIPs), which acts by inhibiting the gastric secretion
(Banic´et al., 2011). However their efﬁcacy is limited by side effects
such as increased risk of bone fractures (Vestergaard et al., 2006)
and several drug–drug interactions (Ogawa and Echizen, 2010). In
this way, there is a clear demand for new therapies for gastric ulcers
and plant extracts, or their isolated compounds, provide a potential
treatment for the disease (Klein-Júnior et al., 2012).
The Copaifera species are popularly known in Brazil as “copaiba.”
These species are large trees that grow mainly in the states of Ama-
zonas, Pará and Ceará localized in Northern Brazil (Veiga-Junior and
Pinto, 2002). The Copaifera oleoresin is a transparent liquid whose
color ranges from yellow to light brown. This oil has been used
in folk medicine as an anti-inﬂammatory, antitumor, antiblenor-
rhagea, urinary antiseptic, and to treat bronchitis and skin diseases
(Veiga-Junior and Pinto, 2002; Paiva et al., 2004; Veiga-Junior et al.,
 Ltda. All rights reserved.
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007; Gramosa et al., 2010; Leandro et al., 2012). Of the 72 species
f trees belonging to the genus Copaifera only seventeen species
ave been chemically studied, and the analyses are limited to the
leoresin (Gramosa et al., 2010; Leandro et al., 2012). Among the
olatile compounds of the oleoresin characterized by GC/MS are the
esquiterpenes -caryophyllene, caryophyllene oxide, -copaene,
-humulene, -muurolene, and -bisabolol (Veiga-Junior et al.,
007). The main non-volatile components belong to the diterpene
lass, including kaurenoic acid, kaurenol, copalic acid, agathic acid,
nd hardwiickic acid (Souza et al., 2011). Palmitic and oleic acids
rom non-polar extract of copaiba seeds have been quantiﬁed by
C/MS (Stupp et al., 2008).
Copaifera langsdorfﬁi Desf., Fabaceae, is a medicinal plant found
n all regions of Brazil. The extracts obtained from their aerial
arts have commercial value and it is an ingredient in beekeeping
nd in cosmetic products (Veiga-Junior and Pinto, 2002; Gramosa
t al., 2010). The hydroalcoholic extract of C. langsdorfﬁi leaves have
een reported to have leishmanicidal and antimalarial activities
Sousa et al., 2012) and to be active in animal models of urolithi-
sis (Brancalion et al., 2012) and nephrolithiasis (Oliveira et al.,
013). The antiulcer activity of the oleoresin from C. langsdorfﬁi
as been previously reported (Paiva et al., 1998, 2004). However
his is the ﬁrst work that reports the therapeutic antiulcer poten-
ial of C. langsdorfﬁi leaves and its major compounds. This study
im to investigate the gastroprotective and healing properties the
. langsdorfﬁi leaves extract and its main isolated compounds using
ifferent animal models of gastric ulcer.
aterial and methods
rugs, reagents and solventes
Cimetidine, omeprazole, carbenoxolone, nitro-l-arginine
ethyl-ester (l-NAME), and N-ethyl-maleimide (NEM) were
cquired from Sigma Aldrich (St. Louis, MD,  USA). All solvents used
or chromatographic analysis were HPLC grade (Tedia, Fairﬁeld,
H, USA). Water was obtained using Milli-Q system (Millipore,
A,  USA). All other reagents and solvents were of analytical grade.
lant material
Copaifera langsdorfﬁi Desf., Fabaceae, leaves were collected in
he Ribeirão Preto in the campus of the University of São Paulo,
razil, at the School of Pharmaceutical Sciences (21◦10′16′′S, 47◦
0′47′′W),  was identiﬁed by Dr. Milton Groppo Junior and a voucher
pecimen (SPFR 10120) was deposited in the herbarium of the
epartment of Biology of the University of São Paulo, Ribeirão Preto,
P, Brazil.
hytochemical methods
Dried and powdered C. langsdorfﬁi leaves (3 kg) were macerated
or 72 h with 70% aqueous ethanol at room temperature and
ercolated. The procedure was repeated three times, and the
ombined hydroalcoholic extract was ﬁltered and concentrated
nder reduced pressure at 50 ◦C furnishing the crude extract
520 g; 17.30%). Following, 50 g of this extract were dissolved in 1 l
f 90% aqueous methanol and sequentially partitioned with 400 ml
f hexanes, chloroform and ethyl acetate (EtOAc). The hexanes
raction (20 g) was fractionated by a sequential series of the three
lassics chromatography on a silica gel 70–230 mesh (Merck)
olumn and the main samples were puriﬁed by preparative thin
ayer chromatography (TLC) furnishing the compounds 1 and 2.
he ethyl acetate crude fraction (6 g) was also submitted to classic
hromatography similarly as described for the hexanes fraction,
nd eluted with increasing amounts of EtOAc in hexanes. The
btained fractions were combined based on similarities in TLC.rmacognosia 25 (2015) 238–245 239
Ten different fractions were obtained. The fraction F1 (1 g) was
fractionated over silica gel 70–230 mesh (Merck) using classic
chromatography and isocratic system, hexanes: EtOAc 9:1 v/v
as mobile phase, to furnish compound 3. The fraction F2 (2 g)
was puriﬁed as described for fraction F1 using isocratic system,
hexanes: EtOAc 4:1 v/v, giving compound 4. The fraction F6 (1 g)
was puriﬁed by semi-preparative reverse-phase HPLC, furnishing
compounds 5 and 6. The chemical structures of these compounds
and its purity levels were determined by GC, HPLC, MS, 1H, 13C,
HMBC and HMQC NMR  (Bruker ARX 400 spectrometer) analyses.
Animals
Swiss mice (25–30 g) were provided by the Central Animal
House of the University of Vale do Itajaí, SC, Brazil. These ani-
mals were housed and cared for in accordance with the Federal
Government Legislation on Animal Care. All experiments were
authorized by the Ethical Committee for Animal Care (protocol
number: 10.1.1800.53.3). The animals were housed in groups of
six, in standard cages, at room temperature (25 ± 3 ◦C), with 12 h
dark/light cycles, and food and water ad libitum.  In all the experi-
ments, the mice were kept in cages with wide-mesh, raised ﬂoor,
to prevent coprophagy. All procedures as described hereafter were
carried out with the mice kept in fasting for 18 h with only water
ad libitum.
Gastroprotective effect against different ulcer models
Ethanol/HCl-induced ulcer model
The mice were divided into ﬁve groups of six animals each
accordingly to published by Mizui and Douteuchi (1983). The ﬁrst
group was given 10 ml/kg of saline used as vehicle, and the sec-
ond group was treated with omeprazole (30 mg/kg). The remaining
three groups received 50, 250 or 500 mg/kg of C. langsdorfﬁi
extract, respectively. In another experiment, isolated compounds
(-humulene, -caryophyllene, caryophyllene oxide, kaurenoic
acid, quercitrin and afzelin) were tested at a dose of 30 mg/kg,
this dose was employed based on omeprazole dose. All treat-
ments were administered orally. One hour after treatment, all mice
received 0.2 ml  of an ethanol/HCl solution (60%/0.3 M)  to induce
gastric ulcer. One hour later, the animals were euthanized and
the stomachs were removed and opened along the greater cur-
vature. The stomachs were gently rinsed with water to remove
the gastric contents and blood clots, for subsequent scanning. The
images obtained were analyzed using speciﬁc “EARP” software
to measure each lesion point. The ulcers areas were classiﬁed as
level I (≤1 mm2); level II, (>1 ≤ 3 mm2); level III, (>3 mm2). The
following parameters were determined: (a) total area of lesion;
(b) percentage of lesion area in relation to total stomach area;
(c) ulcerative lesion index (ULI) as 1 × (number of ulcers level
I) + 2 × (number of ulcers level II) + 3 × (number of ulcers level
III) and (d) curative index, which was determined as follows: %
C = 100 − (ULItreated × 100/ x¯ ULIcontrol).
Nonsteroidal anti-inﬂammatory drug (NSAID)-induced ulcer in
cholinomimetic-treated mice
Five groups of six animals each were randomly separated
accordingly to published procedures (Rainsford, 1987). The
ﬁrst group was  given 10 ml/kg of saline, and the second group
was treated with cimetidine (100 mg/kg). The remaining three
groups received 50, 250 or 500 mg/kg of C. langsdorfﬁi crude extract,
respectively. All the treatments were administered orally. One hour
after treatment, all mice received a combination of indomethacin
(100 mg/kg, p.o.) and bethanechol (5 mg/kg, i.p.)  to induce gastric
ulcer. Five hours after the treatment with NSAID/bethanechol,
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nimals were euthanized and the stomachs were removed and
pened along the greater curvature. The stomachs were gently
insed with water to remove the gastric contents and blood clots,
or subsequent scanning. The images obtained were analyzed
sing the parameters previously described.
ypothermic restraint stress-induced lesions
Groups of six animals (n = 6) were treated, the ﬁrst group was
iven 10 ml/kg of saline used as vehicle, and the second group was
reated with omeprazole (30 mg/kg). The remaining three groups
eceived 50, 250 or 500 mg/kg of C. langsdorfﬁi extract, and 30 min
fter, each animal was placed in a contensor tube and immersed
ertically until the water reached the neck region in a tank with
urrent water at 25 ◦C for 17 h. After this period, the animals
ere euthanized and the stomachs were removed, opened along
he greater curvature, gently rinsed with water to remove gastric
ontents and blood clots to be scanned later. The obtained images
ere analyzed using the parameters described above.
astroprotective action mechanism
etermination of gastric secretion
Groups of six animals each were randomly divided and they
ere anesthetized with ketamine (2 mg/ml; i.p.)  and xylazine
5 mg/ml; i.p.); the abdomen was incised and the pylorus was
igated (Shay et al., 1945). Immediately after pylorus ligature, C.
angsdorfﬁi crude extract was administered at doses of 50, 250 or
00 mg/kg, respectively. Cimetidine (100 mg/kg) was used as pos-
tive control, and 10 ml/kg of saline was administered as negative
ontrol. All the samples were administered intraduodenally. This
oute was used to determine the systemic effect of the extract.
our hours later, the animals were euthanized; the abdomen was
pened and another ligature was placed at the esophageal end.
he stomachs were removed and the gastric content collected and
entrifuged at 3000 rpm (8.000 × g, 25 ◦C, 10 min). The amount of
astric acid (ml) and the pH values were determined. Total acid
ecretion in the gastric juice was determined in the supernatant
olume by titration to pH 7.0 using a 0.01 mol  l−1 NaOH solution,
nd phenolphthalein as indicator.
etermination of mucus in gastric content
The mice being ﬁve groups of six animals each were anes-
hetized with ketamine (2 mg/ml; i.p.)  and xylazine (5 mg/ml; i.p.);
he abdomen was incised and the pylorus was ligated. Immediately
fter pylorus ligature, C. langsdorfﬁi crude extract was  adminis-
ered at doses of 50, 250 or 500 mg/kg, respectively. Carbenoxolone
200 mg/kg) was  used as positive control, and 10 ml/kg of saline
as administered as negative control. All treatments were admin-
stered intraduodenally. The animals were killed four hours after
he treatments. The stomach content was immersed in 10 ml  of
.02% Alcian blue 0.16 M sucrose/0.05 M sodium acetate solution,
H 5.8, and incubated for 24 h at 20 ◦C. The Alcian blue binding
xtract was centrifuged at 3000 × g for 10 min. The absorbance of
upernatant was measured by spectrophotometer at 615 nm.  The
ree mucus in the gastric content was calculated from the amount
f Alcian blue binding per gram of stomach tissue (mg/wt stomach
issue g) (Sun et al., 1991).
ole of nitric oxide in gastroprotectionThe mice were placed randomly in eight cages, with six animals
er cage (Arrieta et al., 2003). Four groups were pre-treated with l-
AME (an inhibitor of nitric oxide synthase), 70 mg/kg (i.p.), and the
ther four groups were pre-treated with saline (1 ml/kg, i.p.). Thirtyrmacognosia 25 (2015) 238–245
minutes later, animals received oral doses of the vehicle (saline),
carbenoxolone (200 mg/kg) or 500 mg/kg of C. langsdorfﬁi crude
extract. After 60 min, all groups received 0.5 ml  (p.o.) of a solution
of ethanol/HCl (60%/0.3 M)  for gastric-ulcer induction. The animals
were euthanized 1 h after the administration of ethanol/HCl, and
the stomachs were removed to determine the percentage of gastric
lesion area.
Role of sulfhydryl groups in gastroprotection
The mice were placed randomly in eight cages, with six animals
per cage. Four groups were pre-treated with NEM (a sulfhydryl
depleter) 10 mg/kg (i.p.) and the other four groups were pre-
treated with saline (1 ml/kg, i.p.) (Matsuda et al., 1999). Thirty
minutes later, animals received oral doses of saline, carbenox-
olone (200 mg/kg) or 500 mg/kg of C. langsdorfﬁi crude extract.
After 60 min, all the groups received 0.5 ml  (p.o.) of a solution of
ethanol/HCl (60%/0.3 M)  for gastric-ulcer induction. The animals
were killed one hour after the administration of ethanol/HCl, and
the stomachs removed to determine the percentage of gastric lesion
area.
Chronic ulcer model
Acetic acid-induced chronic ulcer
The animals were anesthetized with ketamine (2 mg/ml; i.p.)
and xylazine (5 mg/ml; i.p.), and the abdomen was incised. After
exposing the stomach, 0.02 ml  (v/v) of 20% acetic acid solution
was injected into the submucosal layer in the junction between
the antrum and the fundus (Takagi et al., 1969). The stomach
was bathed with saline to avoid adherence to the external sur-
face of the ulcerated region. Then, the stomach was re-internalized
and the cut was sutured. After 24 h, mice were divided into
different groups (n = 6) and treated by gavage with 10 ml/kg of
saline, cimetidine (100 mg/kg) or 500 mg/kg of C. langsdorfﬁi crude
extract once a day during seven days. At the end of the treat-
ments, after 12 h fasting, rats were euthanized. The stomachs were
removed and opened along the greater curvature. The stomachs
were removed and processed as for ethanol/HCl-induced ulcer used
protocol. Also, the curative ratio was calculated by the formula: %
C = 100 − (areatreated × 100/areacontrol).
Toxicity assay
Acute toxicity study
Acute toxicity study was performed as described in “Guidelines
for Testing of Chemicals-Acute Oral Toxicity-Fixed Dose Proce-
dure” (OECD 420, 2001). Five females rats were treated orally with
a single dose of 2000 mg/kg of C. langsdorfﬁi crude extract. After
the administration animals were observed individually at least
once during the ﬁrst 30 min after dosing, periodically during the
ﬁrst 24 h (with special attention during the ﬁrst 4 h) and daily
thereafter for a period of 14 days. Once a day the animals were
observed, principally in relation to changes in skin and fur, eyes
and mucous membrane (nasal) and also autonomic changes (sali-
vation, lacrimation, perspiration, piloerection, urinary volume, and
defecation) and alterations to the central nervous system (ptosis,
drowsiness, gait, tremors and convulsion). Food and water were
provided throughout the experiment.Statistical analysis
The data are reported as mean ± standard error of the mean
(SEM) and were compared using one-way analysis of variance
M.  Lemos et al. / Revista Brasileira de Farmacognosia 25 (2015) 238–245 241
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esults and discussion
Considering that interaction between phytochemistry and
harmacology is essential for development of studies involving
herapeutic potential of vegetable species, the ﬁrst step of this study
as undertake phytochemical analysis of Copaifera langsdorfﬁi
xtract. The GC/MS analyses of the non-polar samples of the leaves
f C. langsdorfﬁi revealed the presence of sesquiterpenes includ-
ng -copaene, -bergamotene, -caryophyllene, -humulene,
aryophyllene oxide, bicyclogermacrene, germacrene D, germa-
rene B, -cadinene and -cadinol. The major compounds in these
amples were -humulene (1) and -caryophyllene (2) which are
esponsible for the anti-inﬂammatory and antimicrobial activi-
ies of Brazillian phytotherapic Acheﬂan® (Fernandes et al., 2007).
aryophyllene oxide (3) kaurenoic acid (4) and -caryophyllene
2) are reported as the major compounds found in copaiba oil
Brancalion et al., 2012). Kaurenoic acid was the major diter-
ene isolated from C. langsdorfﬁi leaves. Caryophyllene oxide was
lso identiﬁed and isolated during the puriﬁcation process. The
hytochemical investigation of the polar extract using HPLC-
V/DAD allowed the isolation, detection and quantization of the
avononoids quercitrin (5) and afzelin (6). These two  compounds
ere considered the major polar compounds and were quanti-
ed monthly for 14 months in the leaves of C. langsdorfﬁi. The
tructures of the compounds 1–6 were conﬁrmed using HPLC, GC,
RMS and NMR  analysis including HSBC, HMBC and comparison
ith the literature (Leandro et al., 2012; Sousa et al., 2012). The
urity of the isolated compounds (Fig. 1) was determined to be
ore than 97% compared with the peak areas detected by GC-FID
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Table  1
Effects of C. langsdorfﬁi extract, omeprazole and cimetidine on gastric lesions in mice induced by ethanol, indomethacin and stress.
Assay Treatment p.o. Dose (mg/kg) Total area of lesion (mm2) % of lesion area Ulcerative lesion index (ULI) Curative index (%)
Ethanol
Vehicle – 54.18 ± 3.43 13.45 ± 2.43 38.88 ± 3.28 –
Omeprazole 30 12.06 ± 3.17** 4.49 ± 1.11** 14.57 ± 1.52** 62.52 ± 3.92
Extract 50 10.11 ± 2.72** 2.80 ± 1.53* 11.12 ± 3.09** 71.38 ± 7.73
250  9.80 ± 1.71** 2.43 ± 0.39* 9.75 ± 1.54** 74.92 ± 3.97
500  6.91 ± 2.38** 1.19 ± 1.21* 7.85 ± 1.92** 79.79 ± 4.93
Indomethacin
Vehicle  – 11.14 ± 1.03 3.33 ± 0.36 20.20 ± 2.39 –
Cimetidine 100 1.25 ± 0.43** 0.33 ± 0.10** 3.60 ± 1.07** 82.17 ± 5.33
Extract 50 5.38 ± 1.39** 1.03 ± 0.25** 6.83 ± 2.15** 59.40 ± 10.07
250  5.12 ± 1.00** 0.78 ± 0.24** 6.60 ± 2.35** 67.32 ± 11.67
500  4.52 ± 1.31** 0.27 ± 0.15** 8.00 ± 1.87** 60.39 ± 9.26
Stress
Vehicle  – 20.29 ± 1.63 5.22 ± 0.45 18.83 ± 1.62 –
Cimetidine 100 0.10 ± 0.09** 0.02 ± 0.02** 0.40 ± 0.40** 97.87 ± 2.12
Extract 50 8.52 ± 2.26** 1.87 ± 0.48** 5.80 ± 2.17** 69.19 ± 11.56
250  5.08 ± 1.43** 1.46 ± 0.48** 4.80 ± 1.68** 74.50 ± 8.95
500  4.44 ± 1.25** 1.55 ± 0.45** 4.66 ± 1.20** 75.21 ± 6.38
Results are shown as mean ± S.E.M. for six mice. Statistical comparison was  performed using ANOVA followed by Dunnett’s post test.
* p < 0.05 and
** p < 0.01 compared to control group
Table 2
Effects of C. langsdorfﬁi extract and cimetidine, administered intraduodenally, on the biochemical parameters of gastric juice in the pylorus-ligature assay.
Treatment (p.o) Dose (mg/kg) Volume (mL) pH [H+] mEq/I/4h
Vehicle – 0.57 ± 0.09 3.56 ± 0.30 69.59 ± 4.34
Cimetidine 100 0.32 ± 0.03* 4.86 ± 0.39* 25.63 ± 4.67*
Extract 50 0.26 ± 0.04* 6.38 ± 0.36* 25.62 ± 6.01*
250 0.23 ± 0.03* 6.25 ± 0.27* 23.29 ± 7.05*
500 0.21 ± 0.03* 5.56 ± 0.33* 32.97 ± 6.41*
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Desults are shown as mean ± S.E.M. for six mice. Statistical comparison was  perform
* p < 0.05 compared to control group.
The experimental models of gastric ulcer have been employed to
nvestigate the pathogenesis of the disease and the efﬁcacy of new
rugs. The administration of ethanol/HCl solution to mice causes
evere damage and disturbances in the gastric mucosa that can lead
o blood vessels rupture, bleeding, sub-epithelial cell exfoliation,
eneration of reactive oxygen species and a severe inﬂammatory
rocess (Shimoyama et al., 2013). In this context, the oral treatment
ith C. langsdorfﬁi extract signiﬁcantly reduced the percentage of
astric injury caused by administration of ethanol/HCl solution
hen compared to control group (vehicle) (p < 0.05) (Table 1). In
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relation to curative ratio, the lowest dose (50 mg/kg) showed a
curative ratio of 71.4%, which was higher than omeprazole (62.5%)
at 30 mg/kg. The results described in Table 1 showed that C. langs-
dorfﬁi leaves extract has gastroprotective effect. This effect may  be
related to the cytoprotective activity of the extract, since it reduced
the severity of ethanol-induced lesions.It is known that indomethacin and other NSAID display ulcero-
genic effects associated with the blockade of Cyclooxygenase-1
(COX-1) in gastric epithelial cells, leading to inhibition of
prostaglandins synthesis (Deoda et al., 2011). Prostaglandins such
** **
/HCl (60%/0.3M)
+
–
–
+
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+
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ne)
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C. langsdorffii
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 500 mg/kg
reated with the inhibitor of nitric oxide synthase (l-NAME) and sulfhydryl depleter
for six mice. Statistical comparison was performed using ANOVA followed by the
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Table  3
Effects of C. langsdorfﬁi extract and carbenoxolone, administered intraduodenally,
on  the binding to free gastric mucus in the pylorus-ligature assay.
Treatment (p.o) Dose (mg/kg) Alcian blue bound (mg/wt
tissue stomach (g))
Vehicle – 3.19 ± 0.62
Carbenoxolone 200 4.30 ± 0.32*
Extract 50 3.93 ± 0.12
250 4.19 ± 0.31*
500 4.57 ± 0.25*
Results are shown as mean ± S.E.M. for six mice. Statistical comparison was per-
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Fig. 3. Effects of C. langsdorfﬁi extract and cimetidine, administered orally, on gastric
lesions induced by acetic acid (30%). The results are shown as mean ± S.E.M. for six
F
formed using ANOVA followed by the Dunnett’s test.
* p < 0.05 compared to control group
s E2 and I2 enhance the synthesis of mucus and bicarbonate, reg-
late the acid secretion and maintain the integrity of the gastric
lood ﬂow in the stomach (Gargallo and Lanas, 2013). The oral treat-
ent with C. langsdorfﬁi extract signiﬁcantly reduced the gastric
njury caused by NSAID/bethanechol administration in comparison
ith the control group (vehicle). The curative ratio of the extract
t 50, 250 and 500 mg/kg were 59.4, 67.3, and 60.4% respectively
Table 1).
Stressful condition is another important factor in the pathol-
gy of gastric ulcer. Stress promotes an increase in the gastric
ecretion, which causes severe damage to the mucus layer that cov-
rs the gastric epithelium (Gupta et al., 2013). Gastric secretion is
timulated by the activation of the vagus nerve and by the inter-
ction of acetylcholine with muscarinic receptors in parietal cells
nd histamine-secreting cells (Schubert and Peura, 2008). Herein
e simulated this situation using the stress-induced ulcer model.
he results showed that oral treatment of mice with C. langsdorfﬁi
xtract reduced the gastric injury when compared to control group
Table 1). This result indicates that the extract may  act by increasing
he gastric mucosa defense factors (e.g.: mucus) or by antagonizing
he histamine H2 receptor.To investigate the ﬁrst hypothesis the pylorus ligature was  per-
ormed in mice. This procedure allows measuring the volume, pH
nd H+ ions concentration present in the gastric juice, as well as the
roduction of mucus. The results showed that the extract decreased
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ig. 4. Effects of compounds of the C. langsdorfﬁi extract and omeprazole, administered or
or  six mice. Statistical comparison was  performed using ANOVA followed by the Dunnetmice. Statistical comparison was performed using ANOVA followed by the Dunnet’s
test. **p < 0.01 compared to control group.
the volume of gastric juice in the stomach (0.26, 0.23 and 0.21 ml  at
50, 100 and 500 mg/kg respectively). The extract also increased the
pH of the gastric juice and decreased the concentration of H+ ions
compared to control (Table 2). Regarding mucus production, the
extract increased mucus production in comparison to the vehicle-
treated group (Table 3). At 500 mg/kg of extract, mucus production
was similar to the carbenoxolone (positive control).
These results are important because the success of the gastric
ulcer treatment relies not only on the blockade of acid secretion,
but also on the augmentation of the protective factors of the gastric
mucosa. The mucus also plays a role in keeping the mucosa pH near
neutral and protecting it from the action of the gastric acid (Santin
et al., 2010).Other important factors to consider in gastroprotection are
nitric oxide (NO) and sulfhydryl groups. Nitric oxide regulates the
inﬂammatory and vascular process in the stomach, controls the
integrity of the gastric mucosa and it inhibits gastric acid secre-
60%/0.3M) p.o
30 mg/kg 30 mg/kg 30 mg/kg 30 mg/kg
e Caryophyllene
oxid
Kaurenoic
acid
Quercetrin Afzelin
ally, on gastric lesions induced by ethanol/HCl. Results are shown as mean ± S.E.M.
t’s test. **p < 0.01 compared to control group.
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ion (Berg et al., 2004). The sulfhydryl groups are responsible for
rotecting the gastric mucosa against oxidative damage (Konturek
nd Konturek, 1995). To investigate the participation of NO and
ulfhydryl groups in the gastroprotective activity of C. langsdorfﬁi
nimals were pre-treated with l-NAME and NEM, a NO inhibitor
nd a thiol blocker, respectively. The data showed that treatment
ith l-NAME and NEM did not affect the gastroprotective effects
f the extract (Fig. 2), suggesting that the gastroprotection pre-
ented by C. langsdorfﬁi extract is not mediated by nitric oxide and
ulfhydryl groups in this case.
Recurrent gastric ulcer can evolve into a chronic inﬂammatory
rocess. Autoimmune disorders and infection by Helicobacter pylori
re among the main factors associated with the recurrence of this
isease, leading to a gradual destruction of the stomach homeosta-
is (Feldman, 2013). To evaluate the effects of C. langsdorfﬁi extract
n chronic ulcer we used the acetic acid chronic ulcer model. This
odel mimics the gastric lesions found in human chronic ulcers
aused by the release of histamine, which increases the capillary
ermeability and back diffusion of HCl. Treatment with C. langs-
orfﬁi extract at the dose of 500 mg/kg once a day for seven days
igniﬁcantly reduced the size of the injury produced by acetic acid
hen compared to control group (Fig. 3).
In the ﬁnal series of experiments the gastroprotective activities
f the main compounds isolated from C. langsdorfﬁi extract were
valuated using the ethanol/HCl-induced ulcer model. The data
btained showed that kaurenoic acid (4), quercitrin (5) and afzelin
6) exhibited gastroprotective activity. The three compounds
educed gastric lesions by 51.45, 60.48 and 60.83%, respectively
Fig. 4). The compounds -humulene (1), -caryophyllene (2) and
aryophyllene oxide (3) showed a greater gastroprotective activity,
educing the gastric lesions by 76.20, 76.57 and 70.17% respec-
ively (Fig. 4). The gastroprotective activity of -caryophyllene (2)
as been previously reported (Tambe et al., 1996). Literature data
how that the compounds quercetin, caryophyllene oxide and -
umulene are present in the chemical composition of extracts and
ssential oils with gastroprotective activity (Esteves et al., 2005;
ima et al., 2012; Zakaria et al., 2014). It is important to empha-
ize that is the ﬁrst time that the gastroprotective activity of (1),
aryophyllene oxide (3), kaurenoic acid (4), quercitrin (5) and
fzelin (6) as pure compounds is showed. These results corrobo-
ate with the literature, which shows that terpenes and ﬂavonoids
xhibit protective effects on gastric ulcer and its activities are asso-
iated with cytoprotective mechanisms (Hiruma-Lima et al., 2006;
iqueira et al., 2012; Klein-Júnior et al., 2012; Santin et al., 2014).
n addition, in the acute toxicity study, no signs of toxicity were
bserved after C. langsdorfﬁi extract administration at the dose of
000 mg/kg, at any time during the observation. The rational of
ECD 420 (2001) permits an acute toxicological classiﬁcation, using
he globally harmonized system (GSH), without pre-determination
f LD50. The GSH classiﬁcation system suggests that if any mortality
as observed when the substance or mixture of substances were
ested up to category 4 (2000 mg/kg), it is classiﬁed as category 5
r low acute toxicity with a LD50 superior to 2000 mg/kg.
Taken together, the data herein obtained shown that C.
angsdorfﬁi leaves extract displayed gastroprotective and healing
roperties in different animal models of gastric ulcer. The gas-
roprotective effects may  be associated with the ability of the
xtract to decrease gastric secretion and increase the produc-
ion of mucus. The extract was also effective in a chronic ulcer
odel and it signiﬁcantly reduced the size of the gastric lesion.
he gastroprotective effects of the C. langsdorfﬁi extract may  be
ssociated with the gastroprotective activity shown by its major
ompounds -humulene, -caryophyllene, caryophyllene oxide,
aurenoic acid, quercitrin and afzelin. Therefore C. langsdorfﬁi
xtract and its isolated compounds have potential as antiulcer
herapy.rmacognosia 25 (2015) 238–245
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